Investor Type | Firm |
Industries | BioTech • FinTech (& Financials services) • Retail (& E-Commerce) • A.I. (& Big Data) • HealthTech (& Fitness) • Life Science |
Investing | United States |
HCS Capital Partners is a Miami-based venture capital firm founded in 2016 with offices in Santiago and Tel Aviv. They specialize in investing in disruptive technology-driven companies across various sectors including healthcare, financial services, and digital marketing, focusing on markets such as Latam, North America, and Israel. They actively seek out businesses that can be disrupted by predictive analytics and machine learning techniques. HCS Capital Partners supports its portfolio companies by providing expertise in four key areas: technology, by defining and implementing IT strategies and developing analytic skills; globalization, by advising when and how to scale up internationally; strategy & operations, by honing the company's strategic approach and assisting in its implementation; and marketing & communications, by structuring partnerships and leveraging effective marketing channels. Their investment approach encapsulates a partnership with both individuals and corporations to bolster growth in areas including telemedicine, population health management, insurance, banking, and digital marketing. The firm operates multiple funds, including HCS Tech Fund I, Corporate Venture Fund II, and HCS Tech Fund III, and prides itself on its team's extensive experience in technology, banking, insurance, operations, and cybersecurity. They aim to partner with entities that are embracing technological advancements in BioTech, FinTech, Retail and E-Commerce, A.I. and Big Data, HealthTech and Fitness, as well as Life Science.